BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
ORGANIZER;CN= NovaBridge Biosciences:MAILTO:no-reply@gcs-web.com
DTEND:
UID:d86266e4-d4e1-4b0a-a434-0899edbff223
DTSTAMP:1793623483
LOCATION:https://mlhnstzab.cc.rs6.net/tn.jsp?f=001CGy7OdRCkZnsFJ76XowMHBgKPE1fFETiGKkkqL1S3s7l_qnXoylJgxKN68Rf9I5rPHDUb0CrximalknOrPF9KOlqhJb555liAAH7oDlFSRZn6B-PAWVS_dX9xoGnwtUHcSCjy2zF9NL8qJqHBA71tqmOs_3Qs7wiBeOIHojDoYPlv67IEx7GvA==&c=zi42BD2S1l8qfUjqUqbUxmE4J4J4va30S4w6E81nYD8_Qa7r-SgqoA==&ch=dVxwyTO_izGFkgq9M86pIx4FLSz97s3aNgF5-TKgiagXY1uUQ3p27g==
DESCRIPTION:Event Details https://www.novabridge.com/events/event-details/givastomig-mature-clinical-data-and-path-registrational-development\n\nWebcast: https://mlhnstzab.cc.rs6.net/tn.jsp?f=001CGy7OdRCkZnsFJ76XowMHBgKPE1fFETiGKkkqL1S3s7l_qnXoylJgxKN68Rf9I5rPHDUb0CrximalknOrPF9KOlqhJb555liAAH7oDlFSRZn6B-PAWVS_dX9xoGnwtUHcSCjy2zF9NL8qJqHBA71tqmOs_3Qs7wiBeOIHojDoYPlv67IEx7GvA==&c=zi42BD2S1l8qfUjqUqbUxmE4J4J4va30S4w6E81nYD8_Qa7r-SgqoA==&ch=dVxwyTO_izGFkgq9M86pIx4FLSz97s3aNgF5-TKgiagXY1uUQ3p27g==
URL;VALUE=URI:https://mlhnstzab.cc.rs6.net/tn.jsp?f=001CGy7OdRCkZnsFJ76XowMHBgKPE1fFETiGKkkqL1S3s7l_qnXoylJgxKN68Rf9I5rPHDUb0CrximalknOrPF9KOlqhJb555liAAH7oDlFSRZn6B-PAWVS_dX9xoGnwtUHcSCjy2zF9NL8qJqHBA71tqmOs_3Qs7wiBeOIHojDoYPlv67IEx7GvA==&c=zi42BD2S1l8qfUjqUqbUxmE4J4J4va30S4w6E81nYD8_Qa7r-SgqoA==&ch=dVxwyTO_izGFkgq9M86pIx4FLSz97s3aNgF5-TKgiagXY1uUQ3p27g==
SUMMARY: NovaBridge Biosciences - Givastomig: Mature Clinical Data and Path to Registrational Development
DTSTART:20261102T130000Z
END:VEVENT
END:VCALENDAR